Loss to Follow-up: A Significant Barrier With DAA Therapies Loss to Follow-up: A Significant Barrier With DAA Therapies

How does loss to follow-up impact treatment effectiveness of DAA regimens for hepatitis C? Which individuals might be at a higher risk of treatment failure due to LTF?Journal of Viral Hepatitis
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news